Michael R. Minogue, President, CEO, Chairman at ABIOMED INC (ABMD), sold 146,800 shares at $105.05 ($15.4M) on 2015-08-18, disclosed to the SEC on 2015-08-20.
Scheduled sale ($15.4M) by President, CEO, Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.05 | 38,126 | $4.0M | 26.0% |
| 2 | $105.92 | 28,530 | $3.0M | 19.6% |
| 3 | $106.77 | 7,214 | $770K | 5.0% |
| 4 | $107.48 | 523 | $56K | 0.4% |
| 5 | $102.91 | 13,996 | $1.4M | 9.4% |
| 6 | $103.78 | 21,601 |
| $2.2M |
| 14.6% |
| 7 | $104.73 | 31,210 | $3.3M | 21.2% |
| 8 | $105.50 | 5,600 | $591K | 3.8% |
| Total | $104.87 avg | 146,800 | $15.4M | 100% |
| Filing → |
| ABMD | SELL | 2021-08-25 | $1.2M | — | Filing → |
| ABMD | SELL | 2021-08-10 | $11.0M | — | Filing → |
| ABMD | SELL | 2021-08-06 | $15.9M | — | Filing → |